High Seroprevalence of Bloodborne viruses among street-recruited injection drug users from Buenos Aires, Argentina

被引:49
作者
Weissenbacher, M
Rossi, D
Radulich, G
Sosa-Estáni, S
Vila, M
Vivas, E
Avila, MM
Cuchi, P
Rey, J
Peralta, LM
机构
[1] Univ Buenos Aires, Fac Med, SIDA, Ctr Nacl Referencia, RA-1121 Buenos Aires, DF, Argentina
[2] Univ Buenos Aires, Hosp Clin Jose San Martin, Dept Hemoterapia & Inmunohematol, RA-1121 Buenos Aires, DF, Argentina
[3] Intercambios Asociac Civil, Buenos Aires, DF, Argentina
[4] El Retono Asociac Civil, Buenos Aires, DF, Argentina
[5] Joint UN Programme HIV AIDS, Geneva, Switzerland
关键词
D O I
10.1086/377560
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 [免疫学];
摘要
Injection drug use is the main mechanism of human immunodeficiency virus (HIV) transmission in Argentina (40% of reported AIDS cases in Argentina). This study was conducted among street-recruited injection drug users (IDUs) from Buenos Aires, with the aim of estimating seroprevalence and coinfection of HIV, hepatitis B virus (HBV), hepatitis C virus (HCV), and human T-lymphotropic viruses (HTLVs). A total of 174 volunteers participated in this study; 137 were men ( 78.7% of volunteers). The average age of the participants was 30 years. Only 64 of participants (37%) had no viral infection, whereas 110 (63%) were infected with greater than or equal to 1 viruses. Seroprevalences were 44.3% for HIV, 54.6% for HCV, 42.5% for HBV, 2.3% for HTLV-I, and 14.5% for HTLV-II. Among the 77 HIV-infected persons, only 6.5% ( 5 persons) were not coinfected with other viruses; 88.3% ( 68) were coinfected with HCV and 68.8% ( 53) were coinfected with HBV. We demonstrated the existence of multiple viral infections with a high rate of prevalence in IDUs in Buenos Aires, Argentina.
引用
收藏
页码:S348 / S352
页数:5
相关论文
共 11 条
[1]
CROFTS N, 2000, 2 ANN M REP GLOB RES, P12
[2]
DARUICH J, 1998, 15 C AS LAT HIG SAN
[3]
The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: A long-term retrospective cohort study [J].
Di Martino, V ;
Rufat, P ;
Boyer, N ;
Renard, P ;
Degos, F ;
Martinot-Peignoux, M ;
Matheron, S ;
Le Moing, V ;
Vachon, F ;
Degott, C ;
Valla, D ;
Marcellin, P .
HEPATOLOGY, 2001, 34 (06) :1193-1199
[4]
ROLE OF DRUG INJECTION IN THE SPREAD OF HIV IN ARGENTINA AND BRAZIL [J].
LIBONATTI, O ;
LIMA, E ;
PERUGA, A ;
GONZALEZ, R ;
ZACARIAS, F ;
WEISSENBACHER, M .
INTERNATIONAL JOURNAL OF STD & AIDS, 1993, 4 (03) :135-141
[5]
*MIN SAL NAC, 2001, EL SIDA ARG INF LUS
[6]
Human immunodeficiency virus/acquired immunodeficiency syndrome prevention in injection drug users and their partners and children:: Lessons learned in Latin America -: The Argentinean case [J].
Rossi, D ;
Goltzman, P ;
Cymerman, P ;
Touzé, G ;
Weissenbacher, M .
CLINICAL INFECTIOUS DISEASES, 2003, 37 :S362-S365
[7]
ROSSI D, 2000, 2 ANN M REP GLOB RES, P68
[8]
Epidemiology of human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome in injection drug users in Argentina:: High seroprevalence of HIV infection [J].
Sosa-Estáni, S ;
Rossi, D ;
Weissenbacher, M .
CLINICAL INFECTIOUS DISEASES, 2003, 37 :S338-S342
[9]
*UN JOINT PROGR HI, 2001, UNAIDS0174E UN JOINT
[10]
WEISSENBACHER M, 1988, 4 INT C AIDS STOCKH